Cantor Fitzgerald Predicts Enovix FY2026 Earnings

Enovix Co. (NASDAQ:ENVX - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2026 earnings estimates for Enovix in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst D. Soderberg expects that the company will earn ($0.97) per share for the year. Cantor Fitzgerald has a "Overweight" rating and a $30.00 price target on the stock. The consensus estimate for Enovix's current full-year earnings is ($1.01) per share.

A number of other brokerages have also recently weighed in on ENVX. Craig Hallum reduced their target price on Enovix from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, February 20th. B. Riley lowered their target price on Enovix from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. dropped their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating on the stock in a research note on Thursday, May 1st. TD Securities cut their target price on Enovix from $10.00 to $7.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. Finally, Benchmark cut their target price on shares of Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, April 15th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $17.27.

Enovix Trading Down 5.0%

Shares of NASDAQ ENVX traded down $0.43 during trading on Tuesday, hitting $8.22. 4,012,937 shares of the company traded hands, compared to its average volume of 5,905,042. The firm has a market capitalization of $1.58 billion, a P/E ratio of -5.67 and a beta of 2.00. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99. The company has a 50-day moving average price of $7.17 and a 200-day moving average price of $8.93. Enovix has a 1 year low of $5.27 and a 1 year high of $18.68.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Deutsche Bank AG lifted its stake in Enovix by 44.8% in the fourth quarter. Deutsche Bank AG now owns 140,606 shares of the company's stock valued at $1,528,000 after buying an additional 43,498 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Enovix by 15.1% in the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock worth $171,458,000 after acquiring an additional 2,063,631 shares during the period. Strong Tower Advisory Services increased its holdings in shares of Enovix by 93.1% in the 1st quarter. Strong Tower Advisory Services now owns 144,045 shares of the company's stock worth $1,057,000 after acquiring an additional 69,435 shares during the period. Haven Private LLC bought a new stake in Enovix in the 4th quarter valued at about $454,000. Finally, Amundi boosted its stake in Enovix by 360.8% during the 4th quarter. Amundi now owns 235,369 shares of the company's stock valued at $2,558,000 after purchasing an additional 184,294 shares during the period. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.